BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15923141)

  • 1. Preventing confusion about side effects in a campaign to eliminate lymphatic filariasis.
    Ramaiah KD; Ravi R; Das PK
    Trends Parasitol; 2005 Jul; 21(7):307-8. PubMed ID: 15923141
    [No Abstract]   [Full Text] [Related]  

  • 2. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV; Kar SK
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
    Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
    J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
    [No Abstract]   [Full Text] [Related]  

  • 4. Elimination of lymphatic filariasis in India.
    Sabesan S; Ravi R; Das PK
    Lancet Infect Dis; 2005 Jan; 5(1):4-5. PubMed ID: 15620551
    [No Abstract]   [Full Text] [Related]  

  • 5. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
    Krentel A; Fischer P; Manoempil P; Supali T; Servais G; Rückert P
    Trop Med Int Health; 2006 Nov; 11(11):1731-40. PubMed ID: 17054754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
    Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S
    J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards elimination of lymphatic filariasis in India.
    Das PK; Ramaiah KD; Augustin DJ; Kumar A
    Trends Parasitol; 2001 Oct; 17(10):457-60. PubMed ID: 11587940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic filariasis: constraints ahead.
    Mishra CP; Singh N
    Indian J Public Health; 2003; 47(1):27-30. PubMed ID: 14723292
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 May; 78(20):171-9. PubMed ID: 12808788
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
    Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. School-based health education campaign--a potential tool for social mobilization to promote the use of DEC-fortified salt towards elimination of lymphatic filariasis.
    Nandha B; Krishnamoorthy K
    Health Educ Res; 2007 Aug; 22(4):539-46. PubMed ID: 17035351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A great success in lymphatic filariasis control in China. National Technical Steering Group for Filariasis Control and Research, MOPH.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):81-5. PubMed ID: 7554168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.
    Ramaiah KD; Vanamail P; Das PK
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):250-5. PubMed ID: 16890256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass drug administration to eliminate lymphatic filariasis in India.
    Ramaiah KD; Das PK
    Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
    Burkot TR; Taleo G; Toeaso V; Ichimori K
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
    Ranganath BG
    J Vector Borne Dis; 2010 Mar; 47(1):61-4. PubMed ID: 20231778
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphatic filariasis elimination programme in India: progress and challenges.
    Ramaiah KD
    Trends Parasitol; 2009 Jan; 25(1):7-8. PubMed ID: 19008150
    [No Abstract]   [Full Text] [Related]  

  • 18. Elimination of lymphatic filariasis.
    Michael E; Malecela-Lazaro MN; Kazura JW
    Lancet; 2006 Jul; 368(9533):362-3; author reply 363-4. PubMed ID: 16876654
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P; Supali T; Maizels RM
    Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.
    Babu BV; Satyanarayana K
    Trop Doct; 2003 Apr; 33(2):79-82. PubMed ID: 12680538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.